1-(2-Chlorobenzyl)-3-phenyl-1h-pyrazole-4-carbaldehyde

Catalog No. :
ACWBPV004
CAS No. :
956986-03-1
Molecular Formula :
C17H13ClN2O
Molecular Weight :
296.76

IUPAC Name:1-(2-chlorobenzyl)-3-phenyl-1H-pyrazole-4-carbaldehyde

1-(2-Chlorobenzyl)-3-phenyl-1h-pyrazole-4-carbaldehyde structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$76.00Login to see priceInquiryInquiry
100mg95%$106.00Login to see priceInquiryInquiry
250mg95%$145.00Login to see priceInquiryInquiry
1g95%$274.00Login to see priceInquiryInquiry
5g95%$719.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(2-Chlorobenzyl)-3-phenyl-1h-pyrazole-4-carbaldehyde
IUPAC Name1-(2-chlorobenzyl)-3-phenyl-1H-pyrazole-4-carbaldehyde
MDL No.MFCD03422334
Molecular FormulaC17H13ClN2O
Molecular Weight296.76
SMILESClC1=CC=CC=C1CN1C=C(C=O)C(=N1)C1=CC=CC=C1
InChI KeyPIGRCLIMEYDNAU-UHFFFAOYSA-N
SynonymART-CHEM-BB B014024;1-(2-CHLOROBENZYL)-3-PHENYL-1H-PYRAZOLE-4-CARBALDEHYDE;AKOS B014024;1-[(2-chlorophenyl)methyl]-3-phenyl-1H-pyrazole-4-carbaldehyde;1-[(2-chlorophenyl)methyl]-3-phenylpyrazole-4-carbaldehyde;1H-Pyrazole-4-carboxaldehyde, 1-[(2-chlorophenyl)methyl]-3-phenyl-
CAS No.956986-03-1

Synthetic Route by SureRoute

1. ACWBPV004 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACYHJI501 route compound structure diagram
    ACYHJI50126033-20-5 In Stock
  4. Then
  5. ACWBPV004 route product structure diagram
    ACWBPV004956986-03-1
Inquiry

2. ACWBPV004 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACYHJI501 route compound structure diagram
    ACYHJI50126033-20-5 In Stock
  4. Then
  5. ACWBPV004 route product structure diagram
    ACWBPV004956986-03-1
Inquiry

Comments (0)